.
Renaming zoonotic diseases and strains, to confuse the general public, and justify ignoring a problem has been one of the more disgraceful veterinary practices in recent years.
We have constantly complained publicly over many years over the situation in Britain. Here is an article from 2009: 'MRSA - No Pets or Flying Veterinarians.'
Once in a while, common sense strikes back, in this case in the most apt and unexpected way:
"VETERINARY MRSA"
Love it! The Dutch government veterinarians continue to come out of this crisis as honest, frank and reliable: professionals with integrity.
They played it straight and will get benefits denied Britain and its devious public relations obsessed veterinary establishment.
Public Relations is about telling the truth, not misleading the public. Britain's vets seem to have missed that bit.
The Dutch know that veterinarians carry MRSA from farm to farm to livestock and farmer, and take it home to their children and into the hospitals. They deal with the problem like adults, not hide it up.
Characterization of Veterinary MRSA: Virulence and transmissibility
| Part of the program | |
| File number | 125010003 |
Summary
Since 2003 a new clone of MRSA (NT-MRSA) That is related to an extensification reservoir in pigs and cattle HAS emerged in The Netherlands. People who are in direct contact with pigs and calves frequently carry this clone. By the end of 2006 nearly 25% of all MRSA strains sent to the national reference center were of this type. There are Indications That this clone Has A reduced transmissibility from human to human, All which would 1) limit its impact on public health and 2) modified justify Control Measures.
The objective of this project is to determining the transmissibility and Virulence or NT-MRSA in comparison with other MRSA strains.
In this prospective study we are Will Investigate how many household members or persons who are carrying MRSA are colonized NT (secondary attack rate) and compare this with household members or other Those who are carrying MRSA strains. Also the occurrence of medical events Will Be Measured During one year to an estimate Regarding the providence Virulence.
MRSA Carriers and Their Relatives Will Be visited by a representative of the public health agency who will take a questionnaire and micro-biological samples. The number of secondary cases in the household is the main outcome measure to determining the secondary attack rate.
The number of infections Occurring Within one year of follow-up is a secondary outcome measure for evaluation of Strain Virulence; other secondary outcomes in this study are part of the antibiotic treatment, duration and Hospitality Localization of MRSA carriage.
The results of this study optimalize Will Be Used to Control Measures for the MRSA.
Involved
| Role | Name | Organization | ||
| Project leader and coordinator | Prof. Dr. JAJW Kluytmans | VU University Medical Center | ||
| Main applicant | Prof. Dr. JAJW Kluytmans | Amphia Hospital | ||
| Administrative head | Prof. Vandenbroucke-Grauls Dr CMJE | VU University Medical Center |
